Eisai Co., Ltd.

This study is monitoring the safety of the drug tazemetostat in real-world clinical practice. It involves 145 Japanese patients with relapsed or hard-to-treat follicular lymphoma who have a specific genetic mutation (EZH2). The main goal is to track side effects and see how well …

This study is testing a new, encapsulated form of a cancer drug (E7389-LF) given together with an existing immunotherapy drug (nivolumab) in people with advanced solid tumors. The first part aims to find a safe and tolerable dose. The second part will see how well the combination…

This early-stage study is testing the safety of an experimental drug called E7090, both alone and combined with other cancer medications. It involves 51 women with advanced, hormone-sensitive breast cancer that has returned or spread. The main goal is to find safe dosage levels a…

This is an early-stage (Phase 1) study to find a safe dose and check the side effects of a new, encapsulated form of a cancer drug called E7389. It is being tested in adults with advanced solid tumors that have not responded to standard treatments. The study will also look at how…

This study will be conducted to assess the safety and tolerability of E7386 in participants with solid tumor including CRC.